Valion Bio, Inc. VBIO
0.48 USD -0.06 (-10.98%)
Regular-session close
0.47 -0.01 -1.58%
After hours · Nov 20, 7:01 PM ET
0.48 Day range 0.5467
0.472 52-week range 67.50
- YTD
- -98.67%
- 1 year
- -98.80%
5D +0.0475 (+9.65%)
- Market cap
- 1.04M
- EPS (ttm)
- -177.91
- YTD return
- -98.67%
- 1-year return
- -98.80%
- Volume
- 137.72K
- Avg volume
- 1.78M
- Open
- 0.54
- Previous close
- 0.5399
- Day's range
- 0.48 – 0.5467
- 52-week range
- 0.472 – 67.50
Fundamental scorecard
3 of 25 checks passed on VBIO’s reported financials
3of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Jun 30, 2026.
Financials — quick view
VBIO Revenue — quarterly 0
VBIO Net income — quarterly -7.10M
VBIO EPS — quarterly -54.00
News
12 Health Care Stocks Moving In Friday's After-Market Session Valion Bio Announces That The Armed Forces Radiobiology Research Institute Will Evaluate The Therapeutic Efficacy Of Entolimod
Valion Bio Announces Final Data From Entolimod Study For Hematopoietic And Gastrointestinal Forms Of Acute Radiation Syndrome; AFRRI Study Found No Evidence Of Treatment-Related Toxicity After One Dose Of Entolimod, Supporting Advancement Toward A Fully Funded Therapeutic Study
Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Monday's Pre-Market Session Valion Bio Confirms Receipt Of Proposed Acquisition Offers For Its Velocity Bioworks; Terms Undisclosed
12 Health Care Stocks Moving In Thursday's After-Market Session
Your note
Sign in to keep a note on VBIO — it syncs with the Stock Master app.
